Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BYZ6: Variant p.Asn488Asp

Rho-related BTB domain-containing protein 2
Gene: RHOBTB2
Feedback?
Variant information Variant position: help 488 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Asparagine (N) to Aspartate (D) at position 488 (N488D, p.Asn488Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (N) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In DEE64; also found in a patient with Rett syndrome-like phenotype. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 488 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 727 The length of the canonical sequence.
Location on the sequence: help LNNEAFMNQEITKAFHVRRT N RVKECLAKGTFSDVTFILDD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LNNEAFMNQEITKAFHVRRTNRVKECLAKGTFSDVTFILDD

Mouse                         LNNEAFMNQEITKAFHVRRTNRVKECLAKGTFSDVTFILDD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 727 Rho-related BTB domain-containing protein 2



Literature citations
Identification of novel genetic causes of Rett syndrome-like phenotypes.
Lopes F.; Barbosa M.; Ameur A.; Soares G.; de Sa J.; Dias A.I.; Oliveira G.; Cabral P.; Temudo T.; Calado E.; Cruz I.F.; Vieira J.P.; Oliveira R.; Esteves S.; Sauer S.; Jonasson I.; Syvaenen A.C.; Gyllensten U.; Pinto D.; Maciel P.;
J. Med. Genet. 53:190-199(2016)
Cited for: VARIANT ASP-488; Missense variants in RHOBTB2 cause a developmental and epileptic encephalopathy in humans, and altered levels cause neurological defects in Drosophila.
Straub J.; Konrad E.D.H.; Gruener J.; Toutain A.; Bok L.A.; Cho M.T.; Crawford H.P.; Dubbs H.; Douglas G.; Jobling R.; Johnson D.; Krock B.; Mikati M.A.; Nesbitt A.; Nicolai J.; Phillips M.; Poduri A.; Ortiz-Gonzalez X.R.; Powis Z.; Santani A.; Smith L.; Stegmann A.P.A.; Stumpel C.; Vreeburg M.; Fliedner A.; Gregor A.; Sticht H.; Zweier C.;
Am. J. Hum. Genet. 102:44-57(2018)
Cited for: VARIANTS DEE64 GLY-452; HIS-461; ASP-488; GLN-489 AND TRP-489; CHARACTERIZATION OF VARIANTS DEE64 GLY-452; HIS-461 AND GLN-489; INVOLVEMENT IN DEE64; INTERACTION WITH CUL3;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.